Patient Adherence & Pharmacist Burden: Implications
Table of Contents
The US healthcare system is undergoing a period of important change, notably concerning drug access and affordability. Evolving policies, tightening formularies, and increasingly complex benefit structures are creating ample barriers for patients, especially those with limited incomes or multiple chronic conditions. Pharmacists are uniquely positioned to play a crucial role in mitigating these challenges, but require expanded knowledge and proactive intervention strategies. This article explores the emerging obstacles to medication access and outlines how pharmacists can prepare to effectively advocate for their patients.
The Looming Challenges to Medication Access
Several converging factors are contributing to a more arduous landscape for patients seeking affordable medications.
Managed Care and Formulary Restrictions
According to Susan Oglesby-Frazier, PharmD, BCPS, a leading voice in oncology pharmacy, we are likely to see a “tightening down of formularies,” particularly within managed care Medicaid systems. This translates to increased utilization of cost-control measures like:
Step Therapy: Requiring patients to try less expensive medications before accessing preferred options.
Tiered therapies: Placing medications into different cost-sharing tiers, influencing out-of-pocket expenses.
Limited Formularies: Restricting the number of drugs covered within a specific therapeutic class.
These strategies, while intended to manage costs, frequently enough create frustration and confusion for patients who may not understand the rationale behind these restrictions. They simply want answers and access to the medications their doctors prescribe.
Medicare and Medicaid Complexity
the intricacies of medicare Advantage,Medicaid,and dual-eligibility programs are notoriously difficult to navigate.Patients frequently enough struggle to understand their coverage options,leading to unintended consequences and potential gaps in care. The addition of potential work requirements for Medicaid eligibility further complicates the situation, particularly for vulnerable populations. As dr. Oglesby-Frazier points out, “You almost have to have a PhD to figure out all of the options available.”
Financial Toxicity and the Need for Support
The rising cost of medications contributes to “financial toxicity,” the hardship patients experience when medical expenses substantially impact their financial well-being. This can lead to medication non-adherence, poorer health outcomes, and increased healthcare utilization in the long run. Pharmacists are increasingly recognizing the need to address these financial barriers directly with patients, administrators, and physicians.
Empowering Pharmacists to Intervene
To effectively address these challenges, pharmacists must proactively expand their knowledge base and embrace a more active role in patient advocacy.
Expanding Knowledge of Benefit Structures
Traditionally, pharmacists haven’t been heavily involved in open enrollment discussions, with financial counselors typically handling these interactions. However, this is changing. Pharmacists need to develop a comprehensive understanding of:
Medicare Parts A, B, C, and D: Including the nuances of Medicare Advantage plans.
Medicaid Programs: State-specific variations and eligibility requirements.
Pharmacy Benefit Manager (PBM) Operations: How formularies are developed and managed.
Patient Assistance Programs: resources available to help patients afford their medications.
This increased knowledge will enable pharmacists to answer patient questions accurately and provide informed guidance during critical enrollment periods. Dr. Oglesby-Frazier emphasizes that this will be a “big lift” over the coming months, requiring dedicated professional progress.
Proactive Benefit Counseling During Open Enrollment
Pharmacists can leverage the Open Enrollment period to provide valuable benefit counseling, particularly for older adults on fixed incomes. This includes:
Reviewing patient Medication Lists: Identifying potential cost-saving opportunities.
Comparing Plan Options: Helping patients understand the differences between available plans.
Assisting with enrollment: Providing support with the enrollment process.
Identifying Patient Assistance Programs: Connecting patients with resources to reduce out-of-pocket costs.
Advocating for clinical Exceptions and Formulary Changes
Pharmacists can also advocate for patients by working with prescribers and payers to secure clinical exceptions or formulary changes. This may involve:
Presenting Clinical Evidence: Demonstrating the value of a non-formulary medication based on patient-specific factors or clinical trial data.
Collaborating with Managed Care Organizations: Engaging in discussions about formulary decisions and advocating for patient access.
Identifying Therapeutic Alternatives: Suggesting clinically appropriate and cost-effective alternatives when possible.
Addressing Financial Toxicity Directly
Pharmacists can initiate conversations with patients about financial toxicity, offering support and resources. This includes:
Discussing Medication Costs: Being transparent about the financial implications of treatment. Exploring Discount Programs: Identifying opportunities for discounts or coupons.
*Connecting patients with Financial